DLA Piper provided legal counsel to Cantor Equity Partners III, Inc. in a special purpose acquisition deal

DLA Piper recently assisted Cantor Equity Partners III, Inc., a special purpose acquisition company sponsored by an affiliate of Cantor Fitzgerald, in finalizing a business combination agreement with AIR Limited, a global provider of hookah and advanced inhalation technologies. This collaboration will result in the formation of a new entity named AIR Global Limited, expected to go public in the United States with a substantial enterprise value of US$1.749 billion. The legal team from DLA Piper, featuring Partners Stephen Alicanti and Sidney Burke based in New York, along with Associates Carina Meleca, Nick Young, and Luke Postma from various locations like Phoenix and Seattle, provided comprehensive legal support for this significant transaction. Additional assistance was rendered by a group of skilled attorneys and counsels from various DLA Piper offices across the United States.

With a strong team of over 1,000 corporate lawyers globally, DLA Piper has a proven track record of successfully executing complex transactions for its clients. The firm has been recognized as the top global performer in M&A volume for an impressive 15 consecutive years, as per data from Mergermarket. Additionally, DLA Piper ranks as a leader in various areas like venture capital, private equity, and M&A, when considering combined global deal volume, according to PitchBook. The firm’s adept team of legal professionals has extensive experience in guiding clients through the intricacies of equity and debt capital markets, public offerings, and other transformative corporate transactions.

By leveraging the firm’s Capital Markets and Public Company expertise, DLA Piper is well-equipped to assist clients in successfully navigating the complexities of securities transactions across the globe. Their Corporate Governance practice provides valuable guidance to reporting companies on matters of securities offerings, corporate governance, and compliance under regulatory frameworks from the SEC, Nasdaq, and NYSE. Boards of directors can rely on DLA Piper’s expertise to handle complex transactions and risk management effectively.

In another recent transaction, Baker McKenzie guided the current shareholders in the sale of their equity interests in Medistream SA, a Swiss corporation holding all equity interests in Citieffe SRL, an Italian medical devices manufacturer, and its subsidiaries in the United States and Mexico, to Poly Medicure B.V., a subsidiary of Poly Medicure Limited, an Indian public company based in Amsterdam, Netherlands. Majority shareholders in Citieffe Group, including global private equity firm ARCHIMED, were advised on this significant deal.

The Citieffe Group, known for its specialization in orthopedic trauma and extremities products, has a strong presence in multiple countries, including the United States, Mexico, and Italy. This particular acquisition is strategic for Poly Medicure, as it opens up new opportunities in the orthopedic market, particularly in the trauma and extremities segment. With enhanced research and development capabilities and potential cost efficiencies from operations in India, the Citieffe Group is poised to benefit significantly from becoming a part of Poly Medicure.

Baker McKenzie provided comprehensive legal and tax advisory services to the shareholders of Citieffe Group and ARCHIMED throughout the transaction, ensuring that all aspects of the deal were handled with precision and expertise.